The aim of our study was to confirm whether LOH/MSI alterations in the selected gene loci in 3p (FHIT, RASSF1A,MLH1,RARβ,VHL) might have important diagnostic and/or prognostic value in NSCLC patients. This evidence concerns the gene RARB and non-small cell lung carcinoma.